OAI letter from USFDA for Lupin's Mandideep facility won't impact future earnings, says HDFC Sec
Updated : March 14, 2019 09:50 AM IST
The US Food and Drug Administration (USFDA) has classified the inspection at Lupin's Mandideep facility in Madhya Pradesh (MP) as 'official action indicated'.
New approvals from this unit may be withheld.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more